Conference Call: Accelerating Alzheimer’s Research & Drug Discovery Through a National Institutional Review Board for Neurodegenerative Diseases.

Click here to listen to a recording using the player below and download the presentation slides by clicking here (PDF).

Ara Khachaturian, PhD, from Prevent Alzheimer's Disease 2020 discussed the development process for a National Institutional Review Board, challenges ahead, and how a well-designed, highly-qualified, and responsive National Institutional Review Board promises to provide better safeguards for clinical trial participants while more efficiently accelerating the scientific enterprise to bend the curve of Alzheimer's disease.

This call was presented by the LEAD Coalition and ResearchersAgainstAlzheimer's.